ARTICLE | Clinical News
Interleukin-1 (IL-1): Began Phase I Trial
January 2, 2001 8:00 AM UTC
Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: Interleukin-1 (IL-1) Cytokine Trap Business: Autoimmune/Inflammation Therapeutic category: Immune suppression Target: IL-1 Description:...